QTTB
Q32 Bio Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.84
+0.86%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$8.96
From 52W high−58.68%
Volume116532.00
Market cap$263.01M
P/E (TTM)3.2x
P/S (TTM)4.9x
Div yield—
Key dataNov 4, 2026
Open
$8.96
From 52W high
−58.68%
Volume
116532.00
Market cap
$263.01M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
4.7x
P/E (TTM)
3.2x
RSI (14)
43.8
MomentumView details →
1D Return
+0.86%
YTD Return
+157.98%
SummaryUpdated Jun 1, 2026
Q32 Bio Inc. (NASDAQ:QTTB) is a clinical-stage biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. Originally incorporated as AdMIRx Inc., the company rebranded to Q32 Bio in April 2020 and went public in March 2018. The company focuses on developing innovative biologic therapeutics designed to restore healthy immune balance in patients suffering from autoimmune and inflammatory diseases caused by pathological immune dysfunction.
Similar companies
Latest newsMore news →